Cancer

Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer

Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.

New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial

Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.

CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial

Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.

Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial

Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.

Cancer Trial Tests Novel Immune Booster BAY 2416964 With Pembrolizumab

Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.

Immunotherapy Combination Shows Promise Against Advanced Sarcoma in Major Trial

Phase II trial tested nivolumab with or without ipilimumab in 164 patients with metastatic sarcoma that couldn't be surgically removed.

Novel Cancer Treatment Combines Surgery with Direct Immune Therapy Delivery

French researchers test intraperitoneal nivolumab after surgery and heated chemotherapy for advanced ovarian cancer patients.

Cancer Vaccine OSE2101 Tested Against Standard Chemotherapy in Advanced Lung Cancer

Phase 3 trial compared therapeutic vaccine OSE2101 to chemotherapy in 219 lung cancer patients after immunotherapy failure.

Time-Restricted Eating Shows Promise for Breast Cancer Survivors Over 60

Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.

Liquid Biopsy Guides Targeted Lung Cancer Treatment in Breakthrough Trial

New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.

Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes

New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.